Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.848% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a COc1ccc(CN(C(=O)c2ccccc2OC)C2CCS(=O)(=O)C2)cc1
b O=C(NCCCN1CCOCC1)c1ccc(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)cc1
c CCn1c(=O)c2sccc2n(CC(=O)NCCC2=CCCCC2)c1=O
Answer: c. CCn1c(=O)c2sccc2n(CC(=O)NCCC2=CCCCC2)c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(=O)c2sccc2n(CC(=O)NCCC2=CCCCC2)c1=O
CCn1c(=O)c2sccc2n(CC(=O)NCCC2=CCCCC2)c1=O
N-[2-(cyclohexen-1-yl)ethyl]-2-(3-ethyl-2,4-dioxothieno[3,2-d]pyrimidin-1-yl)acetamide